These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9378386)

  • 1. K-ras mutations in patients with early colorectal cancers.
    Andreyev HJ; Tilsed JV; Cunningham D; Sampson SA; Norman AR; Schneider HJ; Clarke PA
    Gut; 1997 Sep; 41(3):323-9. PubMed ID: 9378386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
    Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
    Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
    Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
    Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
    Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of K-ras mutations throughout the natural history of human colorectal cancer.
    Losi L; Benhattar J; Costa J
    Eur J Cancer; 1992; 28A(6-7):1115-20. PubMed ID: 1627381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
    Ohba T; Toyokawa G; Osoegawa A; Hirai F; Yamaguchi M; Taguchi K; Seto T; Takenoyama M; Ichinose Y; Sugio K
    Surg Today; 2016 Sep; 46(9):1091-8. PubMed ID: 26711128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
    Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
    Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
    Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
    Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
    Zahrani A; Kandil M; Badar T; Abdelsalam M; Al-Faiar A; Ismail A
    Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type.
    Finkelstein SD; Sayegh R; Christensen S; Swalsky PA
    Cancer; 1993 Jun; 71(12):3827-38. PubMed ID: 8508351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras mutations and prognosis in large-bowel carcinomas.
    Andersen SN; Løvig T; Breivik J; Lund E; Gaudernack G; Meling GI; Rognum TO
    Scand J Gastroenterol; 1997 Jan; 32(1):62-9. PubMed ID: 9018769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras oncogene activation in benign and malignant colorectal tumours.
    Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
    Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma.
    Etoh T; Ueo H; Inoue H; Sato K; Utsunomiya T; Barnard GF; Kitano S; Mori M
    Ann Surg Oncol; 2001 Jun; 8(5):407-12. PubMed ID: 11407514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-ras mutations and prognosis in colorectal cancer.
    Kressner U; Bjørheim J; Westring S; Wahlberg SS; Påhlman L; Glimelius B; Lindmark G; Lindblom A; Børresen-Dale AL
    Eur J Cancer; 1998 Mar; 34(4):518-21. PubMed ID: 9713302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer.
    González-Aguilera JJ; Oliart S; Azcoita MM; Fernández-Peralta AM
    Am J Clin Oncol; 2004 Feb; 27(1):39-45. PubMed ID: 14758132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
    Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
    J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
    Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
    Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
    Lee JC; Wang ST; Lai MD; Lin YJ; Yang HB
    Anticancer Res; 1996; 16(6B):3839-44. PubMed ID: 9042267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
    Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.